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Left atrial (LA) strain is associated with symptomatic status and atrial fibrillation in patients
with hypertrophic cardiomyopathy (HCM). However, hemodynamic determinants of LA res-
ervoir (LARS), conduit, and pump strains have not been examined and data are needed on
the relation of LA strain with exercise tolerance in HCM.
Methods
Fifty HCM patients with echocardiographic and CMR imaging within 30 days were included.
Left ventricular (LV) volumes, mass, EF, scar extent, extracellular volume fraction (ECV),
and LA maximum volume were measured by CMR. Echo studies were analyzed for mitral
inflow, pulmonary vein flow, mitral annulus tissue Doppler velocities, LV global longitudinal
strain, and LA strain. Twenty six patients able and willing to exercise underwent cardiopul-
monary stress testing for peak oxygen consumption (MVO2), and VE/VCO2 slope. Patients
were followed for clinical events.
Findings
LARS was significantly associated with indices of LA systolic function, LV GLS, and LV filling
pressures (P<0.05). Conduit strain was significantly associated with mitral annulus early dia-
stolic velocity and ECV, whereas LA pump strain was determined by LA systolic function
and indices of LV end diastolic pressure (all P<0.05). LARS and conduit strain were signifi-
cantly higher in patients who achieved�80% of MVO2. LARS, conduit, and pump strains
were significantly associated with atrial fibrillation (P<0.05).
Conclusions
LV structure, systolic and diastolic function, and LA systolic function determine the 3 compo-
nents of LA strain. LA strain is associated with exercise tolerance and clinical events in
patients with HCM.
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Introduction
Hypertrophic cardiomyopathy (HCM) is the most common inherited cardiomyopathy and an
important cause of sudden cardiac death and heart failure [1]. The presence of restrictive left
ventricular (LV) filling is a risk factor for heart failure hospitalizations in HCM patients with
normal LV ejection fraction (EF). Restrictive LV filling is characterized in part by reduced left
atrial (LA) contribution to LV filling [2]. Further, LA size is a risk factor for death after surgical
myectomy [3] and has been included in the risk model of sudden cardiac death by ESC [4].
Accordingly, there is ongoing interest in the assessment of not only LA size, but also LA func-
tion in patients with HCM. There are several indices of LA function that have been evaluated
over the years including the changes in LA volume over the different phases of the cardiac
cycle. Such indices were successfully explored to gain insight into LA function after alcohol
septal ablation [5]. More recently, LA strain was examined and has been associated with symp-
tomatic status [6]. However, the hemodynamic determinants of LA strain in patients with
HCM were not evaluated, and there is a paucity of data with respect to LA strain association
with LV structure and a given patient functional status. Accordingly, we sought to gain insight
into the hemodynamic determinants of LA strain in patients with HCM, and their association
with exercise tolerance and clinical outcomes.
Methods
Consecutive HCM patients who underwent echocardiographic and CMR imaging within 30
days over the past 5 years and who met the inclusion criteria (below) were included in the
study. Some of these patients were included in a previous report [7]. Inclusion criteria included
an ejection fraction (EF) > 50%, sinus rhythm, no previous septal reduction therapy, and
imaging by CMR and transthoracic echocardiography. The median difference in time between
the 2 imaging studies was 3.5 days (0–21 days). Patients were excluded if they had coronary
artery disease, the presence of pacemaker or defibrillator not compatible with CMR imaging,
and more than mild aortic valve stenosis or regurgitation. There were no patients with mitral
stenosis or moderate or severe mitral annular calcification. Heart rate and blood pressure were
similar at the time of the two examinations. Imaging was performed after cardiac medications
were withheld. The protocol was approved by Institutional Review Board of Houston Method-
ist Research Institute, and patients provided written informed consent.
Clinical evaluation included the assessment of NYHA functional class, the presence of
angina and its severity, and the occurrence of syncope. Patients underwent symptom limited
exercise treadmill testing on a modified Bruce protocol along with the measurement of peak
oxygen consumption (MVO2), anaerobic threshold, RER (respiratory exchange ratio), and
VE/VCO2 slope.
Echocardiographic imaging and analysis
Patients were imaged with ultrasound systems equipped with a multifrequency transducer.
Parasternal and apical views were acquired. Depth, gain, and transducer position were opti-
mized to allow recording of complete LA volumes without foreshortening. In the apical four-
chamber view, pulsed wave Doppler sample volume was placed at mitral valve annulus and
tips to record mitral inflow at both locations. With color Doppler guidance, LV outflow tract
(OT) gradient was recorded with continuous-wave (CW) Doppler. Pulsed wave tissue Doppler
was applied to record mitral annulus velocities at septal and lateral sides of the mitral annulus.
Peak velocity of tricuspid regurgitation (TR) was recorded by CW Doppler from multiple win-
dows. Pulmonary regurgitation velocity, when available, was recorded by CW Doppler.
PLOS ONE LA Strain in HCM
PLOS ONE | https://doi.org/10.1371/journal.pone.0245934 February 10, 2021 2 / 15
All measurements were performed by an observer blinded to clinical and CMR data. Mitral
annulus diastolic diameter was measured in the apical views, and mitral annulus area was then
calculated [8]. Peak LVOT gradient was derived with the modified Bernoulli equation as:
LVOT gradient = 4v2, where v = peak velocity in LVOT by continuous-wave Doppler in m/s
[9]. Mitral inflow was analyzed for peak early (E), late (A) diastolic velocities, E/A ratio, and
deceleration time (DT) of mitral E velocity. LA ejection force was calculated using the equa-
tion: 0.5 × 1.06 × mitral annulus area × (peak A velocity)2 in kdyne [10]. In calculation of LA
ejection force, absolute A velocity (peak A–E velocity at onset of A) was used when A velocity
did not start at baseline. Pulmonary artery (PA) systolic pressure was derived as: (peak TR
velocity by CW Doppler in m/s)2 + right atrial pressure [11]. Pulmonary artery (PA) diastolic
pressure was derived as: (end diastolic PR velocity by CW Doppler in m/s)2 + right atrial pres-
sure [11]. Right atrial pressure was estimated based on inferior vena cava maximum diameter
and its change with respiration and hepatic venous flow [11].
Pulmonary vein flow was analyzed for peak velocity, duration, and velocity time integral of
systolic (S), diastolic (D), and atrial reversal (Ar) velocities. The time difference between dura-
tion of pulmonary vein Ar velocity and mitral A velocity was computed (Ar-A) as an index of
LV end diastolic pressure. A wave transit time, was measured between onset of A velocity at
mitral inflow and onset of A velocity at LVOT with the sample volume located midway
between LVOT and mitral valve. This time interval is shorter in the presence of increased LV
stiffness and end diastolic pressure [12]. Mitral annulus early diastolic velocity (e’) was mea-
sured at septal and lateral sides of the mitral annulus (septal and lateral), and average E/e’ ratio
was computed [12].
LV global longitudinal strain (GLS), and LA strain were analyzed offline using VVI (Syngo,
Siemens) as the average of 3 beats using R-R gating. Mean interobserver difference for LA res-
ervoir strain was 1.8±0.6%, whereas it was 2±0.8% for LA pump strain. All analyses were per-
formed by a single observer blinded to clinical data, CMR and other echocardiographic
measurements. Peak LA reservoir strain (LARS) during LV systole and peak LA pump strain
were measured. LA conduit strain was then derived [13, 14]. LA stiffness index was obtained
as the ratio of average E/e’ to LARS [12]. Statistical analysis was performed using LA strain val-
ues from the apical 4-chamber view [14].
CMR imaging and analysis
CMR studies were performed on 3 Tesla MR system (Verio, Siemens Healthcare, Germany).
Steady state free precession sequences were used to acquire a stack of short axis images at 1 cm
interval during single breath holds, slice thickness of 6 mm with 4 mm gap, echo time = 1.33
ms, temporal resolution = 37.56 ms, flip angle 65˚ to 85˚, repetition time 3.0 ms, phases = 20,
field of view = 400 mm, field of phase = 81.3 m. Quantification of left and right ventricular
ejection fraction (EF), volumes (end diastolic: EDV, end systolic: ESV and stroke volume: SV),
and mass were calculated as per recommended guidelines [15]. The endocardial borders were
manually traced for end diastolic and end systolic images for all slices. Papillary muscles were
excluded from ventricular volumes. LA volume was determined using biplane area-length
method [16].
Late gadolinium enhancement (LGE) imaging was performed 10–15 min after intravenous
injection of a gadolinium contrast agent (gadopentetate dimeglumine or gadoterate meglu-
mine, 0.15 mmol/kg). An EKG triggered inversion recovery gradient echo sequence was
applied during a breath hold in long axis (4, 3, 2 chamber view slices) and short axis slices
copying the scanning parameters of the corresponding cine images. The presence and extent
of scar using LGE was performed offline by an experienced level 3 reader. Quantification of
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LGE was done according to the full width half maximum method which has excellent repro-
ducibility [17].
The ECG triggered modified Look Locker inversion recovery (MOLLI) sequence was
employed for assessment of myocardial T1 relaxation time in a mid-ventricular slice. Native
myocardial T1 relaxation time was measured before administration of contrast. Acquisition
scans for post contrast T1 mapping were performed after the standard delayed enhancement
acquisition protocol for a mid-ventricular matching slice, approximately 15–20 min after the
infusion of the contrast agent. Parameters for MOLLI technique include slice thickness of 6
mm, voxel size 2.1x1.6 x 6 mm, TE = 1.09, TR = 675, flip angle = 350, 2-fold parallel imaging.
Pre-contrast 5(4)2 and post-contrast 4(1)2(2)2 heartbeat sampling schemes were used on the
3.0-Tesla scanner. Shimming and delta frequency adjustments were applied to minimize off-
resonance artifacts.
Extra cellular volume (ECV) fraction was assessed at 6 myocardial segments using post pro-
cessing software cvi42 software, Circle cardiovascular imaging, Calgary, Canada. ECV fraction
was calculated from the pre and post contrast images [18]. Briefly, an offline post processing
analysis of T1 values was performed using manually contoured region of interests by a level 3
reader independent from the LGE analysis, for both pre and post contrast midventricular slices
and ECV was calculated as: ECV = Δ R1 myocardium / Δ R1 blood × (100 − HCT), where Δ
R1 myocardium or change in relaxation rate is given by: 1 / T1 myocardium post contrast
injection– 1 / T1 myocardium pre-contrast injection, and Δ R1 blood = 1 / T1 blood-post con-
trast– 1 / T1 blood-pre contrast administration. By this technique an estimate of T1 is encoded
in the intensity of each pixel. Using 17 segment model proposed by AHA, ECV, T1 pre- con-
trast and T1 post contrast values were calculated separately for each of the six segments in the
midventricular slice before and after contrast administration. Myocardial segments with any
artifacts were excluded. For computing purposes, an average of global ECV was calculated
weighted by the number of segments where it was possible to assess ECV. An offset of 20%
from epicardial and endocardial contours was applied to the T1 sequences to reduce bias from
partial volume effects.
Outcome events
The study cohort was followed for the clinical events of atrial fibrillation, stroke, heart failure
hospitalizations, and death. Mean follow-up was 77 months (6.4 years). Atrial fibrillation diag-
nosis was ascertained based on clinical records and EKG evidence of the arrhythmia. EKG evi-
dence was based on recordings obtained during clinic visits, loop recorders, and Holter
monitors.
Statistical analysis
Numerical data are presented as mean ± standard deviation and categorical data as absolute
number along with their percentage. Distribution of numerical data was tested for normality
using Kolmogorov Smirnov test. Independent student t-test or Mann-Whitney U test were
used to compare the numerical data, while chi-square test was applied to compare categorical
data. A comparison between patients with and without significant LVOT obstruction at rest
(LVOT gradient� 30 mmHg) was performed for the complete dataset. Regression analysis
was used to assess the correlates of LA strain with CMR and echo indices of LV and LA struc-
ture and function. Furthermore, these correlations were derived again adjusting for age and
resting LVOT gradient using partial correlation. Univariable binomial logistic regression was
performed for the study outcome using clinical and imaging parameters, including LA strain.
LA strain was compared between patients who achieved�80% of predicted MVO2 for age and
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sex, and those who did not. Linear correlation was performed for the association of LA strain
with VE/VCO2 slope. Significance was defined by two-tailed P <0.05. All statistical analyses
were performed using R (version 3.5.0) and SPSS version 26 (IBM Corp., Armonk, N.Y.,
USA).
Results
Table 1 presents a summary of clinical and exercise data of the study group. Most patients
were symptomatic and were on beta-blockers and/or calcium channel blockers. The majority
had abnormal LV and LA functions as reflected in LV GLS and LA strain measurements.
Table 1. Baseline clinical, exercise data, and LA strain of the study sample.
Variable Total (n = 50)
Age, years 54.8±14.1
Gender (Men), n (%) 30 (60.0)
Hypertension, n (%) 29 (58.0)
Diabetes, n (%) 5(10)
Beta blocker therapy, n (%) 31 (62)
Calcium channel blocker therapy, n (%) 5 (10)
NYHA class, n (%)
Class I 21 (42%)
Class II 15 (30%)
Class III-IV 14 (28%)
Angina n (%) 10 (20%)
ESC Score 2.5±1.6
Exercise Data (N = 26)
Duration (min) 11± 5.1
Pre-stress HR, beats/min 64±13
Post-stress HR, beats/min 133±28
Pre-stress SBP, mm Hg 133±14
Pre-stress DBP, mm Hg 69±12
Post-stress SBP, mm Hg 162±19
Post-stress DBP, mm Hg 80±8
Anerobic threshold ml/kg/min 12.7±4.2
MVO2 ml/kg per min 21.2±7.4
Percentage of target MVO2 Achieved 79.8±25.9
MVO2 80% of predicted achieved, n (%) 13 (50%)




LV GLS (absolute %) 15.1±4.3
LA reservoir strain, % 35.3±17.1
LA conduit strain, % 23.6±13.0
LA pump strain, % 11.7±7.4
NYHA = New York Hear Association class, HR = heart rate, SBP = systolic blood pressure, DBP = diastolic blood
pressure, MVO2 = peak myocardial oxygen consumption, VE = minute ventilation, VCO2 = carbon dioxide
production, LV = left ventricle, GLS = global longitudinal strain, LA = left atrium, ESC = European Society of
Cardiology
https://doi.org/10.1371/journal.pone.0245934.t001
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LV and LA structure and function
A summary of LV volumes, EF, and mass is shown in Table 2. RV volumes and EF were nor-
mal. Most patients had asymmetric septal hypertrophy. LA maximum volume index by CMR
was increased but there was no evidence of delayed hyperenhancement in the LA. LA maxi-
mum volume index was significantly larger in patients with dynamic obstruction (64±12 vs. 53
±17 ml/m2, P = 0.01). Expectedly, myocardial scar was present in non-CAD pattern, and mean
ECV fraction was 30%. Mitral regurgitation was present in 29 patients with an average regurgi-
tant fraction of 30%. None of the patients had intrinsic mitral valve disease. There was a trend
towards lower LV GLS and LA strain values (reservoir and conduit) in patients with dynamic
obstruction compared to patients without, but the difference was not statistically significant.
Examples of LA strain are shown in Fig 1.
Hemodynamic determinants of LA Reservoir Strain (LARS)
LARS was related to LV GLS, such that patients with more LV systolic deformation had larger
LARS values (Table 3). However, LARS was not related to LV volumes, mass/volume ratio, scar
burden, or ECV. The strongest correlation was present between LARS and pump strain (r = 0.7,
P<0.01, Fig 2). Likewise, significant direct relation was present between LARS and average a’
velocity by tissue Doppler. Indicators of elevated LV EDP had significant correlations with LARS
(short A wave transit time is associated with increased LVEDP hence its direct relation with
LARS). Mitral annulus e’ velocity had a significant direct relation. Reduced LARS was associated
with elevated PA pressures, though the correlation did not reach statistical significance (Table 3).
Hemodynamic determinants of LA conduit strain
LA conduit strain was significantly and directly related to e’ velocity (Fig 2). LA conduit strain
was higher in patients without scar than in those with scar, but the difference was not
Table 2. CMR imaging findings of the study sample.
Variable Total (n = 50) Variable Total (n = 50)
LV end-diastolic volume (mL) 135.8±37.9
LV end-diastolic volume index (mL/m2) 67.3±15.6
LV end-systolic volume (mL) 33.7±18.5
LV end-systolic volume index (mL/m2) 16.5±7.9
LV cardiac output (Liters/min) 6.6±1.8
LV mass (gm) 229.5±86.3 MR volume (mL) 32.4±20
LV mass index (gm/m2) 113.5±38.3 MR fraction (%) 29.8±11.8
LV Mass/Volume ratio (gm/mL) 1.7±0.6 LA diameter (cm) 4.4±0.8
LV stroke volume (mL) 102±24.2 LA volume (mL) 117.9±35.8
LV ejection fraction (%) 76.2±7.2 LA volume index (mL/m2) 58.6±16.0
RV end-diastolic volume index (mL/m2) 63.3±16.0 Septal thickness (cm) 1.9±0.6
RV end-systolic volume index (mL/m2) 23.6±9.5 Inferolateral wall thickness (cm) 1.1±0.3
RV ejection fraction (%) 63.5±8.6 Extracellular volume fraction (%) 29±3
LV hypertrophy pattern LGE, n (%) 42 (84.0)
Apical Hypertrophy 4 (8.0) LGE percentage 5.6± 5.7
Asymmetric Hypertrophy 44 (88.0) Scar mass (gm) 14.5±18.2
Concentric Hypertrophy 2 (4.0)
LV = left ventricle, MR = mitral regurgitation, LA = left atrium, LGE = late gadolinium enhancement, RV = right ventricle
https://doi.org/10.1371/journal.pone.0245934.t002
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statistically significant (29±6.4% vs 22.6±11.8%, P = 0.19). On the other hand, LA conduit
strain had a significant inverse relation with ECV, and Ar-A duration.
Hemodynamic determinants of LA pump strain
LA pump strain was significantly and directly related to indices of LA systolic function including
mitral inflow A velocity, mitral annulus a’ velocity, and LA ejection force. On the other hand, it
was inversely related to (Ar-A) duration (Fig 2), and LV end diastolic volume. Similar to LARS,
A wave transit time was directly related to LA pump strain. A wave transit time shortens with
increased LV EDP, and thus the direct relation between A wave transit time and LA pump strain.
Relation between LA strain and exercise tolerance
There were 26 patients who were able to and agreed to exercise. LARS and LA conduit strain, but
not pump strain, were significantly higher in patients who achieved�80% of predicted maximum
oxygen consumption than in those who did not (Fig 3). LA stiffness index was significantly lower
in patients who achieved�80% MVO2, compared to patients who did not (0.16±0.03 vs 0.27
±0.08, P<0.001). Further, LARS (β coefficient: -0.23, P = 0.02) and LA pump strain (β coefficient:
-0.29, P = 0.009), but not conduit strain, were significantly related to VE/VCO2 slope.
Fig 1. Examples of left atrial (LA) strain from a patient who achieved�80% of MVO2 (upper panel), and another patient who did not reach 80% MVO2
(lower panel).
https://doi.org/10.1371/journal.pone.0245934.g001
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Relation of LA strain to clinical events
There were 11 patients who developed atrial fibrillation and one patient died (24% of patients
had events). The were no strokes, or hospitalizations for heart failure. Table 4 shows the associ-
ation of all variables with the outcome events. LARS, LA conduit, and pump strains were all
associated with clinical events. The results were unchanged when atrial fibrillation was the
only outcome considered. Table 5 shows the accuracy of the cutoff values of LA strain mea-
surements in relation to outcomes.
Discussion
In patients with HCM, LARS is related to LV GLS, LV filling pressures, and LV elastic recoil.
LARS is also related to LA pump function. LA conduit strain is determined by LV early dia-
stolic recoil as inferred by mitral annulus e’ velocity and ECV. LA pump strain is primarily
determined by LA systolic function and LA afterload. Patients who achieved 80% of MVO2
had higher LARS and LA conduit strain and lower LA stiffness index. VE/VCO2 slope was sig-
nificantly related to LARS and LA pump strain. All LA strain measurements were related to
clinical events.
LA reservoir strain
LA reservoir strain is a measure of LA expansion during systole taking into account the initial
volume of the atrium at the onset of systole. LA filling occurs as LA pressure falls below pulmo-
nary vein pressure allowing for forward flow into the LA. Thus, the lower the LA systolic
Table 3. Correlations of left atrial strain parameters.
Variables Number Reservoir Conduit Pump
Left atrial volume 50 0.01 0.18 -0.3�
LV EDV 50 0.05 0.27 -0.35�
LV Mass 50 -0.02 0.06 -0.15
LV volume/mass 50 -0.1 -0.16 0.05
LV stroke volume 50 0.08 0.3� -0.36�
E/E’ average 44 -0.24 -0.19 -0.21
E’ average 44 0.52��� 0.69��� 0.13
A’ average 43 0.4�� 0.15 0.64���
IVRT 39 -0.16 -0.26 0.06
A wave transit time 48 0.39� 0.1 0.67���
Pulmonary vein A reversal velocity 33 -0.28 -0.22 -0.25
Ar-A duration 34 -0.51�� -0.36� -0.77��
PA systolic pressure 19 -0.28 -0.24 -0.28
PA diastolic pressure 12 -0.42 -0.14 -0.51
LA ejection force 49 0.14 -0.01 0.49���
LV GLS 49 0.33� 0.3� 0.32�
ECV 40 -0.29 -0.39� -0.03
scar mass 50 -0.04 -0.01 -0.07
LV = left ventricle, EDV = end-diastolic volume, IVRT = isovolumic relaxation time, PA = pulmonary artery, LA = left atrium, GLS = global longitudinal strain,
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pressure, the higher forward systolic flow into the LA. The first phase of forward systolic flow
occurs during LA relaxation with the drop in LA pressure. LA systolic and diastolic functions
are tightly coupled [19, 20]. In an animal study, LA a’ velocity was directly related not only to
Fig 2. Upper row: Relation of LA reservoir strain to left ventricular global longitudinal strain (GLS) shown in the left panel and to LA pump strain in right panel.
Middle row: Relation of LA conduit strain to mitral annulus early diastolic velocity (e’) shown in the left panel and to extracellular volume fraction (ECV) by CMR in
right panel. Lower row: Relation of LA pump strain to the difference between pulmonary vein atrial velocity (Ar) duration and mitral inflow late diastolic velocity (A)
duration shown in left panel. Relation of LA pump strain to average mitral annuls late diastolic velocity (average of septal and lateral velocities, (a’) by tissue Doppler
shown in right panel.
https://doi.org/10.1371/journal.pone.0245934.g002
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Fig 3. Box plots of LA reservoir (left), conduit (middle), and pump (right) strain of HCM patients who achieved�80% of MVO2, and those who did not reach 80%
MVO2.
https://doi.org/10.1371/journal.pone.0245934.g003
Table 4. Factors associated with clinical events on univariate analysis.
Variables Odds ratio (95% CI) P value
Age 1.01 [0.97;1.07] 0.450
Hypertension 1.02 [0.27;3.80] 0.979
LV end-diastolic volume index 0.99 [0.95;1.03] 0.604
LV Mass Index 0.99 [0.98;1.01] 0.515
LVEF 1.00 [0.92;1.10] 0.919
LGE 2.48 [0.27;22.54] 0.419
IVRT 0.99 [0.95;1.03] 0.581
E’ avg 1.07 [0.73;1.57] 0.732
E/E’ avg 0.99 [0.89;1.09] 0.816
GLS 0.91 [0.76;1.08] 0.267
LA Ejection Force 0.62 [0.13;2.99] 0.556
A wave transit time 0.98 [0.95;1.02] 0.445
Average a’ velocity 0.98 [0.96;1.01] 0.281
LVOT gradient 1.01 [1.00;1.03] 0.107
LA Reservoir strain 0.86 [0.78;0.96] 0.005
LA Conduit strain 0.89 [0.81;0.98] 0.019
LA Pump strain 0.80 [0.66;0.96] 0.016
LA Stiffness index 5.43 (0.94;31.55) 0.059
LV = left ventricle, EF = ejection fraction, LGE = late gadolinium enhancement, ECV = extra cellular volume,
IVRT = isovolumic relaxation time, GLS = global longitudinal strain, LA = left atrium, LVOT = left ventricular
outflow tract
https://doi.org/10.1371/journal.pone.0245934.t004
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LA dP/dt, but also to the invasive index of LA relaxation: [(Pa-Px)/Pa]/(tx-ta), where Pa refers
to the peak pressure of LA a wave, Px refers to the trough of LA x wave, and (tx-ta) is the time
interval between the x trough and peak of a wave [20]. Therefore, when LA contractility is nor-
mal, LA relaxation is preserved leading to lower LA pressure in early systole, increased LA sys-
tolic filling and thus higher LA reservoir strain. This explains the direct relation between LA
reservoir and indices of LA systolic function in this study. The second phase of forward systolic
flow occurs with LV contraction and mitral annulus descent towards the apex, leading to
another drop in LA pressure (x’ drop in LA pressure recording) and hence the significant
direct association shown here in HCM patients, and in patients with mitral valve regurgitation
between LV GLS and LA reservoir strain [21]. In this study, the statistical association between
LA reservoir strain and LV GLS was adjusted by age and LVOT gradient. This is likely due to
the decrease of LV GLS with age and dynamic gradient which increases LV systolic pressure
and thus afterload. Increase in LV afterload leads to lowering of LV GLS as GLS is dependent
on loading conditions. At the same time LARS decreases with age and with dynamic obstruc-
tion which is often accompanied by increased LA pressure and lower LARS. LA reservoir
strain is also dependent on LA stiffness and given the positive association between LA stiffness
and LA pressure, it is not surprising to see the negative association between LA reservoir strain
and the surrogates of LV filling pressures.
LA conduit strain
LA conduit strain is a measure of the change in LA volume during early diastole. LA volume
decreases in early diastole with transmitral flow into the LV. This occurs secondary to a drop
in LV pressure in early diastole with LV relaxation and early diastolic elastic recoil. The signifi-
cant and direct relation of LA conduit strain with mitral annulus e’ velocity shows the depen-
dence of this metric of LA function on LV early diastolic properties, given the known
association between e’ velocity and LV relaxation and elastic recoil [20, 22]. MR is expected to
directly relate to LA conduit strain but since these patients had mostly mild MR, such a rela-
tion was not observed given the narrow range of MR volumes as measured by CMR. ECV as
measured by CMR had a significant inverse relation with LA conduit strain which may be
explained by the detrimental effect of increased fibrosis on LV diastolic function.
LA pump strain
LA pump strain is directly dependent on LA systolic function. This is supported by direct and
significant association with all indices of LA systolic function evaluated in this study, including
mitral annulus a’ velocity, and LA ejection force. Of note in an animal study, LA a’ velocity
was directly related to LA dP/dt [20]. Another significant determinant of LA pump strain
shown in this report is LA afterload. LV late diastolic pressures reflect LA afterload and have a
negative association with LA a’ velocity [20]. Likewise, both indices of LV end diastolic pres-
sure: Ar-A duration and A wave transit time were significantly related to LA pump strain in
this study. Interestingly, the strength of the correlation of LA pump strain with indices of LA
systolic function was rather similar to its association with LV end diastolic pressure. Given the
Table 5. Cutoff values for LA strain for the clinical events of atrial fibrillation and death.
Variable AUC Threshold Sensitivity Specificity
Pump 0.80 (95% CI 0.66–0.90, P = 0.0001) �6% 67% 87%
Conduit 0.76 (95% CI 0.62–0.87, P = 0.0006) �21% 92% 55%
Reservoir 0.86 (95% CI 0.73–0.94, P<0.0001) �27% 92% 76%
https://doi.org/10.1371/journal.pone.0245934.t005
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direct correlation between LA strain and LA systolic function, it may be more useful than
other indices of LA function in predicting atrial fibrillation in HCM, similar to other patient
populations [23].
LA strain, exercise tolerance, and clinical events
Given the importance of LA function in maintaining normal LA pressure and adequate LV fill-
ing, LA strain was significantly associated with peak oxygen consumption and with VE/VCO2
slope as lower LARS and pump strain were accompanied by increased wasted ventilation. The
observation in patients with HCM is similar to that in other patient populations where LARS
was associated with exercise tolerance [24]. Given the sample size, additional studies are
needed to corroborate these findings which if true would lead to the recommendation of tak-
ing account of all LA strain measurements: reservoir, conduit, and pump in HCM patients.
Likewise, the association noted in this study of LA strain with clinical events, mostly atrial
fibrillation, is similar to other studies showing the association of LA volumes by echocardiog-
raphy with outcomes in patients with HCM [3, 25], and LA reservoir and conduit strain with
paroxysmal atrial fibrillation [26, 27].
Limitations
Most of the patients did not undergo cardiac catheterization and thus the evaluation was lim-
ited to noninvasive measurements of LV and LA hemodynamics. Notwithstanding, the nonin-
vasive measurements obtained in this study have all been validated against the invasive
standards, including invasive indices of LA systolic function and LA relaxation [12, 20], LV
systolic function, and LV end diastolic pressure [28–30]. Only 50 patients were enrolled pri-
marily due to the inclusion criterion of enrolling only patients with both CMR and echocar-
diographic imaging within 30 days. While we have shown associations, given the
pathophysiological implications of these associations, we believe the study contributes to gain-
ing insights into the hemodynamic determinants and the clinical relevance of LA strain. ECV
was measured at midventricular level and could be different in apical segments in patients
with apical hypertrophy. Therefore, we may have underestimated the extent of ECV in the
four patients with apical HCM. There were few events in the study which limits the ability to
address the incremental value of LA strain over clinical and other echocardiographic measure-
ments. However, only LA strain was associated with clinical outcomes and the findings are
very similar to other studies in HCM patients which included more patients and more events
[26, 27]. Given the small number of events and the concerns with collinearity in multivariable
models, multivariable analysis was not pursued, and we could not address which of the strain
measurements has the most prognostic value.
Clinical implications
LA reservoir strain has been advocated as an index of LA pressure based on clinical studies
showing its significant association with mean wedge pressure [12, 13]. However, as noted in
this study, LA reservoir strain is not a pure metric of LA pressure since it is significantly
affected by LA systolic/diastolic properties and LV systolic function. Therefore, caution should
be exercised when drawing inferences about LA pressure based on LA reservoir strain in
HCM.
LA conduit strain is an interesting parameter that merits further evaluation as it provides
another index of LV early diastolic recoil, albeit an indirect index. It remains to be seen how it
relates to LV early diastolic properties in the presence of significant MR. LA pump strain is an
index of LV end diastolic pressure [13], albeit also dependent on LA systolic function. Using
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multivariable regression models, it is possible to draw inferences about LV late diastolic pres-
sures once LA systolic function is accounted for. Further, LA pump function may prove to be
an important predictor of atrial fibrillation and stroke in HCM. These findings likely apply to
most patients with cardiac disease but additional studies are needed for confirmation.
There are recent attempts aimed at standardizing LA strain analysis that when adopted by
most labs can increase the feasibility and consistency of LA strain measurements [14]. Given
the fact that LA strain can now be readily obtained and measured online on most ultrasound
systems, it is possible to include its value in the standard report and to consider it in reaching
recommendations pertaining to patient management, particularly LA reservoir and pump
strain in HCM patients for prediction of atrial fibrillation with potential inclusion in future
guidelines for risk stratification and management.
Further for LA strain to be useful clinically in a given patient, the value should be outside
the normal range. A recent meta-analysis [31] in 2542 normal subjects reported the normal
value for LA reservoir strain at 39% with 95% confidence intervals of 38–41%. The corre-
sponding value for LA conduit strain was 23.6% (95% CI: 21–25%), and for LA pump strain
was 17% (95% CI: 16–19%). Of note, the mean values for LARS (35.3%), and LA pump strain
(11.7%) in this group of HCM patients were less than the lower 95% CI for the corresponding
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